EN DE

Inspiration Healthcare Group (IHC) Fair Value & Analysis

Healthcare · GB · Market cap 15.7M GBX

IH Inspiration Healthcare Group IHC · LSE
Price£0.1750
Fair Value£0.2125
Upside+21.4%
Quality54/100
Watch Inspiration Healthcare Group for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Loss-making · -2.2% net margin
Low debt · generates free cash flow
Mixed vs. peers (7/12)
Narrow moat 19/100
Evidence: High Range £0.1360 – £0.2890 Share as image

Fair value as of: Jul 17, 2026

From 16 valuation models · updated 24 days ago

Share price −5.1% over the past month.

A solid business, screening 21% undervalued on our models.

What matters now

  • Solid quality (54/100) at a price below fair value, the discount is the argument here, not the business quality.
  • A fairly wide model range (£0.1360 to £0.2890) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

£1.39 £0.1182 Fair Value £0.2125 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.

How to read this chart

60‑month range £0.1182 – £1.39 · fair‑value band £0.1360 – £0.2890 · the £0.1750 price screens below the £0.2125 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 17, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Inspiration Healthcare Group (IHC) currently trades at £0.1750, while our model-based Fair Value estimate is £0.2125, implying the stock looks roughly 21.4% undervalued today. The Quality Score stands at 54/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Inspiration Healthcare Group generated revenue of £45.2M at a net margin of -25.3%. Revenue grew 40.8% year over year. It earns a return on equity of -51.6%. Net debt stands at £10.6M. Fundamentals as of Jul 17, 2026

Our scenario range runs from £0.1360 (bear case) to £0.2890 (bull case); at £0.1750, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Healthcare peers we cover trades at -22% fair-value upside, at 21%, IHC screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF £0.7400 £1.19 £1.97 80
Rev-Margin DCF £0.2900 £0.4400 £0.6600 74
ROIC Compounder £0.0100 £0.0100 £0.0100 72
All 16 models by family
DCF Models
FCF DCF £0.7900 £1.13 £2.10 38
Owner Earnings £0.0200 £0.0600 31
5Y Revenue Exit £0.2900 £0.3900 £0.5600 39
5Y EBITDA Exit £0.4300 £0.6800 £1.13 41
10Y Revenue Exit £0.4600 £0.7000 £0.8200 36
10Y EBITDA Exit £0.5500 £0.9300 £1.56 37
Earnings-Based
EPV £0.0100 £0.0100 £0.0100 59
Dividend Discount
Gordon GGM £0.0300 £0.0500 £0.0700 70
DDM Multi-Stage £0.0300 £0.0500 £0.0600 61
Multiples
EV/EBIT £0.0400 £0.0700 £0.0900 53
EV/EBITDA £0.2500 £0.3400 £0.4300 54
EV/Revenue £0.0200 £0.0400 £0.0700 43
Asset-Based
NCAV (Graham) £0.0900 £0.1200 £0.1700 50
Growth DCF
Growth DCF £0.7400 £1.19 £1.97 80
Rev-Margin DCF £0.2900 £0.4400 £0.6600 74
Economic Profit
ROIC Compounder £0.0100 £0.0100 £0.0100 72

Widest divergence: DCF Models (£0.6800) versus Earnings-Based (£0.0100). Highest evidence: Growth DCF (80).

Notify me when IHC reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 45.2M GBX
Revenue growth (YoY) +40.8%
Net margin -25.3%
Return on equity -51.6%
Free cash flow 6.3M GBX FY2026
Operating margin 1.0%
More key figures
EPS (TTM) £-0.1400
EPS growth (YoY) -65.1%
Net debt 10.6M GBX FY2026

Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 54/100

Of which business quality 55 · Market factors (momentum, volatility) 30

Profitability 42
Margins and returns on capital today
Quality Growth 88
Are margins and returns improving?
Cashflow 70
Earnings quality: real cash, not paper profit
Fin. Strength 43
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 44
Calm price path (market factor)
Momentum 23
Price trend over the last 3–12 months (market factor)
52W Momentum 26
Distance to the 52-week high (market factor)
Net Issuance 0
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Inspiration Healthcare Group plc designs, manufactures, and sells medical technology products worldwide. The company offers products for acute care comprising developmental and intensive care, monitoring, neonatal, obstetrics, operating theatres, pain management and developmental, respiratory, resus, thermo regulatory, and transport areas.

Full company description

Inspiration Healthcare Group plc designs, manufactures, and sells medical technology products worldwide. The company offers products for acute care comprising developmental and intensive care, monitoring, neonatal, obstetrics, operating theatres, pain management and developmental, respiratory, resus, thermo regulatory, and transport areas. It also offers infusion therapies and products, such as ambulatory infusion pumps, administration sets, accessories, patient infusion management systems, and medical infusion devices for acute pain management, obstetrics, parenteral nutrition, palliative care, oncology, immunoglobulin therapy, antibiotic infusion, and other, as well as manufactures and sells pneumatic ventilators. The company serves the hospital sector. Inspiration Healthcare Group plc was incorporated in 1998 and is based in Croydon, the United Kingdom.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Inspiration Healthcare Group reported revenue of £47.5M in FY2026 versus £41.1M in FY2022, a compound +3.7%/yr. Reported net income was −£1.0M in FY2026.

Growth Quality 46/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2026)
£47.5M
Latest YoY
+24.3%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.9%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.2%
Avg. growth/yr (27Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+25.3%
Revenue +3.7%/yr
FY22 £41.1M
FY23 £41.2M
FY24 £37.6M
FY25 £38.3M
FY26 £47.5M
Net income
FY22 £4.2M
FY23 £272K
FY24 −£6.0M
FY25 −£15.0M
FY26 −£1.0M

Watch IHC: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Inspiration Healthcare Group Fair Value". https://www.fairvalue-calculator.com/stock/IHC

Peer Group

Medical Devices · 352 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 54 · Above median
Fair Value upside +21% · Top 25%
Return on assets 1% · Below median
Net margin (TTM) -2% · Below median
Operating margin (TTM) 2% · Below median
Revenue growth 11% · Above median
Debt / equity 0.26× · Higher than median

Valuation Multiples vs Medical Devices median · lower = cheaper

P/B 1.35× · Cheaper than median
P/S (TTM) 0.45× · Cheaper than 75% of peers
P/FCF 3.4× · Cheaper than median
EV/EBITDA 9.7× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 62 · sector 0
FUTURE 56 · sector 29
PAST 0 · sector 8
HEALTH 87 · sector 97
DIVIDEND 0 · sector 38

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $100.68 $74.79 -26%
Stryker Corporation SYK $316.44 $186.28 -41%
Medtronic plc MDT $83.56 $65.57 -22%
Boston Scientific Corporation BSX $43.04 $38.44 -11%
Edwards Lifesciences Corporation EW $85.73 $41.02 -52%
Siemens Healthineers AG SHL €34.59 €33.87 -2%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥149.43 ¥147.63 -1%
Shanghai United Imaging Healthcare Co 688271 ¥109.00 ¥43.60 -60%
Demant A/S DEMANT kr 276.60 kr 161.17 -42%
Getinge AB GETIB kr 206.80 kr 192.14 -7%

Compare Inspiration Healthcare Group with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Inspiration Healthcare Group (IHC) overvalued or undervalued?
As of Jul 17, 2026, our model estimates a fair value of £0.2125 versus a price of £0.1750, about +21% (undervalued).
What is the fair value of IHC?
Our model-based fair value for Inspiration Healthcare Group is £0.2125 (as of Jul 17, 2026), built from audited fundamentals. The current price is £0.1750.
What is the quality score of IHC?
Inspiration Healthcare Group has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Inspiration Healthcare Group (IHC)?
Inspiration Healthcare Group reported trailing-twelve-month revenue of about £45.2M (latest available figure, as of Jul 17, 2026).
What is the net profit margin of IHC?
The net profit margin of Inspiration Healthcare Group is about -25.3%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Inspiration Healthcare Group and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.